share_log

Oppenheimer Maintains Outperform on Pharming, Raises Price Target to $40

Benzinga ·  Mar 28, 2023 09:58

Oppenheimer analyst Michael Carrier maintains Pharming (NASDAQ:PHAR) with a Outperform and raises the price target from $36 to $40.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment